Introduction
Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.pfizerah.co.uk
Gletvax 6
Introduction
Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.pfizerah.co.uk
Presentation
A suspension for injection, each 5 ml dose containing:
Cell-free pilus antigen of K88ab | 100-135 units |
Cell-free pilus antigen of K88ac | 100-135 units |
Cell-free pilus antigen of K99 | 190-250 units |
Cell-free pilus antigen of 987P | 2900-3100 units |
Purified toxoids of Cl. perfringens Type B and purified toxoids of Types C and D | Together contributing not less than 300 international unit equivalents beta toxoid and not less than 200 International Unit equivalents of epsilon toxoid |
Each dose also contains the adjuvant Aluminium hydroxide (less than 15 mg aluminium) and the excipient Thiomersal (0.01% w/v).
Uses
A combined E. coli and Cl. perfringens Type B, C and D vaccine for pigs. For the passive protection of piglets by the active immunisation of breeding sows and gilts to prevent neonatal colibacillosis caused by K99 bearing strains of E. coli; to reduce neonatal colibacillosis caused by K88ab, K88ac and 987P bearing strains of E. coli and Cl. perfringens Type C necrotising infectious enteritis.
Dosage and administration
Dose
Sows and gilts: 5 ml.
Administration
By subcutaneous injection preferably behind the ear. The bottle should be well shaken before vaccine is withdrawn.
Primary vaccination scheme
The initial course consists of two doses:
First dose: given at service or, if necessary, at any time up to 6 weeks before farrowing.
Second dose: given two weeks before farrowing is expected.
Re-vaccination scheme
Given two weeks before farrowing is expected.
Contra-indications, warnings, etc
Vaccinate only healthy animals.
The vaccine is safe for use during pregnancy. No information is available on specific use during lactation.
Occasional hypersensitivity reactions may occur. Prompt subcutaneous administration of adrenalin may relieve the condition.
Syringes and needles should be sterilised before use and the injection should be made through an area of clean, dry skin, taking precautions against contamination.
In most pigs, a slight to moderate swelling (up to 6 cm) may be seen at the injection site after vaccination. The swelling will decline and disappear but may last from 14 to 21 days in some pigs. No increased reactions have been seen after administration of an overdose.
Withdrawal period
Zero days.
Pharmaceutical precautions
Store and transport between +2°C and +8°C. Protect from light. Do not freeze. Use immediately after broaching.
Do not mix with any other medicinal products.
No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with the product.
Any unused veterinary medicinal product or waste materials derived from the use of such veterinary medicinal products should be disposed of in accordance with local requirements.
For animal treatment only.
Keep out of the reach of children.
Legal category
POM-VPS
Packaging Quantities
50 ml plastic packs.
Further information
In any animal population there may be a small number of individuals which fail to respond fully to vaccination. Successful vaccination depends upon correct storage and administration of the vaccine together with the animal's ability to respond. This can be influenced by such factors as genetic constitution, intercurrent infection, age, the presence of maternally-derived antibodies, nutritional status, concurrent drug therapy and stress.
Marketing authorisation number
Vm 00057/4283.
Significant Changes
Updated following the transfer to Pfizer Animal Health | 11/09/2009 |